Article Information
History
- April 10, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- 1Early Clinical Development, Pfizer Worldwide R&D, Cambridge, MA 02139
- 2Inflammation & Immunology Research Unit, Pfizer WRD, Cambridge, MA 02139
- Corresponding author: Baohong Zhang Early Clinical Development Pfizer Worldwide R&D Cambridge, MA 02139 Email address: baohong.zhang{at}Pfizer.com
↵* These two authors contributed equally to the manuscript